Biotechnology and Pharmaceutical Executives from New England's Top Companies to Attend the Second Annual Convergence - The Life Sciences Leaders Forum.MARTHA'S VINEYARD Martha's Vineyard (vĭn`yərd), island (1990 est. pop. 8,900), c.100 sq mi (260 sq km), SE Mass., separated from the Elizabeth Islands and Cape Cod by Vineyard and Nantucket sounds. , Mass. -- Second Annual Convergence convergence Mathematical property of infinite series, integrals on unbounded regions, and certain sequences of numbers. An infinite series is convergent if the sum of its terms is finite. - The Life Sciences Leaders Forum
WHO: Speakers for the event include, but are not limited
to the following executives:
-- John Abele, PhD, Dir., Founder & Chairman - Boston
Scientific Corporation
-- Noubar Afeyan, PhD, Managing Partner - Flagship Ventures
-- Joseph Bolen, PhD, Senior VP of Discovery Research -
Millennium Pharmaceuticals
-- Lee Brettman, MD, FACP, President, CEO and Director -
Dynogen Pharmaceuticals, Inc.
-- Maggie Flanagan, PhD, Global Alliance Director for Global
Sciences and Information - AstraZeneca Pharmaceuticals
-- Jeff Elton, PhD, SVP of Strategy and COO - Novartis
Institutes for Biomedical Research
-- Wendy Everett, ScD, President - New England Healthcare
Institute
-- Thomas Finneran, President - Massachusetts Biotech Council
-- Jean-Francois Formela, MD, Senior Partner - Atlas Venture
-- Michael Gilman, PhD, Executive VP of R&D - Biogen Idec
-- Robert Gould, PhD, VP, Licensing and External Research -
Merck Research Labs Boston
-- Sylvie Gregoire, CEO - GlycoFi
-- Steven Holtzman, President and CEO - Infinity
Pharmaceuticals, Inc.
-- Glenn Larsen, PhD, CSO - Hydra Biosciences
-- John Maraganore, PhD, CEO - Alnylam Pharmaceuticals
-- Bennett Shapiro, PhD, Former Executive VP of Worldwide
Licensing - Merck & Co.; Director - PureTech Ventures
-- Jean-Pierre Sommadossi, PhD, CEO - Idenix Pharmaceuticals
Inc.
WHAT: Convergence - The Life Sciences Leaders Forum
(www.convergenceforum.com) will bring together high-level
life sciences players to discuss and debate the most
pressing topics of interest to the industry - topics like
forging strong corporate partnerships; attracting funding
from private and public sources; building successful
research organizations; streamlining product development
and approval; understanding the coming convergence of
biology, software, and medical devices; and staying ahead
of regulatory changes.
WHEN & WHERE
June 9-11, 2005
Mansion House
9 Main Street
Vineyard Haven on Martha's Vineyard
|
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion